Last reviewed · How we verify
NCT06089109
Creating VIP Corps to Reduce Maternal Deaths
NA trial testing The Big 3 in Maternal Morbidity and Mortality in 2,800 participants. Currently enrolling.
29 September 2026
Quick facts
| Lead sponsor | Ann Coker |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 2,800 |
| Start date | 25 September 2023 |
| Primary completion | 29 September 2026 |
| Estimated completion | 29 September 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- The Big 3
- Implementation and Effectiveness of VIP Corps Training
Conditions studied
- Maternal Morbidity and Mortality — all drugs for Maternal Morbidity and Mortality →
Sponsor
Ann Coker
Who can join
Adults 18 to 30, any sex, with Maternal Morbidity and Mortality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to create and rigorously evaluate a violence intervention and prevention corps (VIP Corps) training using a randomized controlled trial among undergraduate and professional students; and to develop a novel maternal injury surveillance system (MISS) to complement an existing maternal violent death registry in Kentucky.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06089109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ann Coker trials
Trials by the same sponsor.
- NCT05722769 — CSTOP Now! Child Sex Trafficking Stops With You · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06089109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ann Coker
- Last refreshed: 7 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06089109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing